Hydroxychloroquine Sulfate

   
Google
 
Web NewDrugInformation.com

Hydroxychloroquine Sulfate


Drug - Hydroxychloroquine Sulfate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydroxychloroquine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 200MG
The potency of the active ingredient(s), Hydroxychloroquine Sulfate. May repeat for multiple part products.

Applicant - SANDOZ
The firm name holding legal responsibility for Hydroxychloroquine Sulfate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040150
The FDA assigned number to Hydroxychloroquine Sulfate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hydroxychloroquine Sulfate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 27, 1996
The date Hydroxychloroquine Sulfate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hydroxychloroquine Sulfate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Hydroxychloroquine Sulfate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sandoz Inc
The full name of the firm holding legal responsibility for the new application of Hydroxychloroquine Sulfate.

Hydroxychloroquine Sulfate